You are here

Forty Seven

It’s a record! Biotech IPO frenzy outpaces 2017 in half the time as 4 new arrivals on Nasdaq raise $556M

It’s a record! Biotech IPO frenzy outpaces 2017 in half the time as 4 new arrivals on Nasdaq raise $556M

Endpoints

Neon Therapeutics

Aquestive Therapeutics

Flag link:

The Biotech IPO Rush Continues With Four More Coming Soon

The Biotech IPO Rush Continues With Four More Coming Soon

CP Wire

Neon Therapeutics

Flag link:

The Biotech IPO Rush Continues With Four More Coming Soon

Neon Therapeutics

Flag link:

Genentech beefs up its PD-L1 combo pipeline, signing the ‘don’t eat me’ specialists at Forty Seven

Genentech beefs up its PD-L1 combo pipeline, signing the ‘don’t eat me’ specialists at Forty Seven

Endpoints

anti-PD-1 immunotherapy

Flag link: